Research Article

Antimicrobial-Resistance Profile of Helicobacter pylori, Obtained from Endoscopic Patients in Bahir Dar, North West Ethiopia

Table 2

Multidrug-resistance profile of H. pylori isolates from patients with gastric-associated diseases attending endoscopic examination.

AntibioticsR3 N (%)R4 N (%)R5 N (%)R6 N (%)

CLM + AMX + MTZ13 (54.2)
CLM + AMX + CPR10 (41.7)
CLM + AMX + AUG12 (50.0)
CLM + AMX + TET6 (23.0)
CLM + MTZ + CPR10 (41.7)
CLM + MTZ + TET6 (23.0)
CLM + MTZ + AUG12 (50.0)
CLM + CPR + TET4 (17.0)
CLM + CPR + AUG8 (33.0)
CLM + TET + AUG5 (21.0)
CLM + AMX + MTZ + TET5 (21.0)
CLM + AMX + MTZ + CPR9 (37.0)
CLM + AMX + MTZ + AUG11 (45.8)
CLM + AMX + TET + CPR4 (17.0)
CLM + AMX + CPR + AUG8 (33.3)
CLM + AMX + MTZ + CPR + TET3 (13.0)
CLM + AMX + MTZ + CPR + AUG7 (29.2)
CLM + AMX + TET + CPR + AUG3 (13.0)
CLM + AMX + MTZ + CPR + TET + AUG3 (13.0)

R 3, R4, R5, and R6 are resistant for 3, 4, 5, and 6 antimicrobials.